SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-030051
Filing Date
2023-04-17
Accepted
2023-04-17 09:00:10
Documents
13
Period of Report
2023-04-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea177035-8k_aditxt.htm   iXBRL 8-K 26334
2 SHAREHOLDER UPDATE DATED APRIL 17, 2023 ea177035ex99-1_aditxt.htm EX-99.1 26329
  Complete submission text file 0001213900-23-030051.txt   234619

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adtx-20230417.xsd EX-101.SCH 3221
4 XBRL LABEL FILE adtx-20230417_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE adtx-20230417_pre.xml EX-101.PRE 22355
7 EXTRACTED XBRL INSTANCE DOCUMENT ea177035-8k_aditxt_htm.xml XML 3693
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 23822984
SIC: 2834 Pharmaceutical Preparations